AU1281900A - Process for oxidising terpenes - Google Patents

Process for oxidising terpenes

Info

Publication number
AU1281900A
AU1281900A AU12819/00A AU1281900A AU1281900A AU 1281900 A AU1281900 A AU 1281900A AU 12819/00 A AU12819/00 A AU 12819/00A AU 1281900 A AU1281900 A AU 1281900A AU 1281900 A AU1281900 A AU 1281900A
Authority
AU
Australia
Prior art keywords
sub
mutant
cells
amino acid
oxidising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12819/00A
Other languages
English (en)
Inventor
Stephen Graham Bell
Angus Bishop Carmichael
Luet Lok Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU1281900A publication Critical patent/AU1281900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU12819/00A 1998-11-19 1999-11-19 Process for oxidising terpenes Abandoned AU1281900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9825421.2A GB9825421D0 (en) 1998-11-19 1998-11-19 Process for oxidising terpenes
GB9825421 1998-11-19
PCT/GB1999/003873 WO2000031273A2 (en) 1998-11-19 1999-11-19 Process for oxidising terpenes

Publications (1)

Publication Number Publication Date
AU1281900A true AU1281900A (en) 2000-06-13

Family

ID=10842737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12819/00A Abandoned AU1281900A (en) 1998-11-19 1999-11-19 Process for oxidising terpenes

Country Status (7)

Country Link
US (1) US7211420B1 (enExample)
EP (1) EP1131440B1 (enExample)
JP (2) JP4886930B2 (enExample)
AT (1) ATE510021T1 (enExample)
AU (1) AU1281900A (enExample)
GB (1) GB9825421D0 (enExample)
WO (1) WO2000031273A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914373D0 (en) 1999-06-18 1999-08-18 Isis Innovation Process for oxidising aromatic compounds
CN100482789C (zh) 1999-07-27 2009-04-29 Basf公司 酶的电子供体系统及其在底物生物化学转化中的用途
MY126592A (en) * 1999-07-27 2006-10-31 Basf Ag Novel cytochrome p450 monooxygenases and their use for the oxidation of organic compounds
GB0002201D0 (en) * 2000-01-31 2000-03-22 Imperial College Process
AU2002307340A1 (en) 2001-04-16 2002-10-28 California Institute Of Technology Peroxide-driven cytochrome p450 oxygenase variants
WO2003008563A2 (en) 2001-07-20 2003-01-30 California Institute Of Technology Improved cytochrome p450 oxygenases
US7524664B2 (en) 2003-06-17 2009-04-28 California Institute Of Technology Regio- and enantioselective alkane hydroxylation with modified cytochrome P450
EP1660646B1 (en) 2003-08-11 2014-12-31 California Institute Of Technology Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use
US8715988B2 (en) 2005-03-28 2014-05-06 California Institute Of Technology Alkane oxidation by modified hydroxylases
US11214817B2 (en) 2005-03-28 2022-01-04 California Institute Of Technology Alkane oxidation by modified hydroxylases
US8026085B2 (en) 2006-08-04 2011-09-27 California Institute Of Technology Methods and systems for selective fluorination of organic molecules
US8252559B2 (en) 2006-08-04 2012-08-28 The California Institute Of Technology Methods and systems for selective fluorination of organic molecules
WO2008073498A2 (en) * 2006-12-12 2008-06-19 The Regents Of The University Of California Artemisinic epoxide and methods for producing same
US8802401B2 (en) 2007-06-18 2014-08-12 The California Institute Of Technology Methods and compositions for preparation of selectively protected carbohydrates
GB0719620D0 (en) 2007-10-08 2007-11-14 Isis Innovation Mutant Enzymes
WO2010019489A2 (en) * 2008-08-13 2010-02-18 Salk Institute For Biological Studies Method for making terpene derivatives
WO2013016207A2 (en) 2011-07-22 2013-01-31 California Institute Of Technology Stable fungal cel6 enzyme variants
EP2773751B1 (en) * 2011-11-01 2017-03-01 Firmenich SA Cytochrome p450 and use thereof for the enzymatic oxidation of terpenes
HUE044211T2 (hu) * 2012-08-31 2019-10-28 Glaxosmithkline Biologicals Sa Staphylococcus aureus elleni immunizálásra szolgáló, stabilizált fehérjék
CA2943690A1 (en) 2014-03-31 2015-10-08 Boehringer Ingelheim Vetmedica Gmbh Improved modular antigen transportation molecules and uses therof
EP3183353A2 (en) 2014-08-21 2017-06-28 Givaudan S.A. Process for producing oxygenated products of valencene
CN107896481B (zh) 2015-05-18 2021-07-06 齐姆特罗尼克斯公司 磁力固定化的杀微生物酶
CN109788762B (zh) 2016-08-13 2023-07-11 齐姆特罗尼克斯催化系统股份有限公司 磁性固定化的杀生物酶和杀生物化学品
EP3548175A4 (en) * 2016-12-03 2020-08-05 Zymtronix Catalytic Systems, Inc. MAGNETICALLY IMMOBILIZED METABOLIC ENZYMES AND COFACTOR SYSTEMS
EP3858986A1 (en) 2020-02-03 2021-08-04 Bayer Aktiengesellschaft P450 bm3 monooxygenase variants for c19-hydroxylation of steroids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB334841A (en) 1929-06-04 1930-09-04 John Pinder Theft alarm or signal for use on motor vehicles
DE3629890A1 (de) 1986-08-29 1988-03-10 Schering Ag Mikroorganismen und plasmide fuer die 2,4-dichlorphenoxyessigsaeure (2,4-d)-monooxigenase - bildung und verfahren zur herstellung dieser plasmide und staemme
FR2693207B1 (fr) 1992-07-03 1994-09-30 Orsan Souche de levure permettant la co-expression d'une activité mono-oxygénase de cytochrome P450 hétérologue et d'une NADPH-cytochrome P450-réductase endogène ou hétérologue et son utilisation à des fins de bioconversion.
GB9422205D0 (en) 1994-11-03 1994-12-21 British Gas Plc Enzyme mutant and method
GB2306485B (en) 1995-11-01 1998-12-09 British Gas Plc Enzyme mutant
AU716583B2 (en) * 1995-11-01 2000-03-02 Bg Plc Mutant mono-oxygenase cytochome P450cam
US5763237A (en) 1996-05-21 1998-06-09 Board Of Trustees Operating Michigan State University Method for production of monoterpene derivatives of limonene

Also Published As

Publication number Publication date
EP1131440B1 (en) 2011-05-18
JP2012010707A (ja) 2012-01-19
JP2002530112A (ja) 2002-09-17
WO2000031273A2 (en) 2000-06-02
EP1131440A2 (en) 2001-09-12
JP4886930B2 (ja) 2012-02-29
JP5611151B2 (ja) 2014-10-22
GB9825421D0 (en) 1999-01-13
WO2000031273A3 (en) 2000-08-17
ATE510021T1 (de) 2011-06-15
US7211420B1 (en) 2007-05-01

Similar Documents

Publication Publication Date Title
AU1281900A (en) Process for oxidising terpenes
WO2000047758A3 (en) Methods of making compounds
JP2002530112A5 (enExample)
CA2161537A1 (en) Acidising underground reservoirs
ATE234930T1 (de) Enzymatische herstellung von homogentisinsäure
WO2002095187A3 (en) Methods of well treatment
NO20025503D0 (no) FremgangsmÕte som omfatter den indirekte elektrokjemiske regenerering av NAP(P)H
WO2001021825A3 (en) Novel enzymes which dehydrate glycerol
PT873411E (pt) Mutantes melhorados da (2,5-dkg) redutase a
WO2002051988A3 (en) Thymic epithelial progenitor cells and uses thereof
AU6338799A (en) Method for enzymatic splitting of rutinosides
AU2002246065A1 (en) Methods and means for detecting enzymatic cleavage and linkage reactions
NO921439L (no) Fremgangsmaate for fremstilling av glyoksylsyre ved enzymatisk oksidasjon av glykolsyre
Srivastava et al. " Dehydrogenase" and" Oxidase" Reactions of Medium-Chain Fatty Acyl-CoA Dehydrogenase Utilizing Chromogenic Substrates: Role of the 3', 5'-Adenosine Diphosphate Moiety of the Coenzyme A Thioester in Catalysis
IL70833A0 (en) Enzymatic conversion of waterinsoluble organic substrates
ATE307494T1 (de) Zusammensetzung, welche pektinmethylesterase und zwei substrate beinhaltet
WO1998028400A3 (en) Enzymatic bleach composition
NO20014260L (no) Flerkomponentsystem for enzymkatalysert oksidasjon av substrater, og fremgangsmåter for enzymkatalysert oksidasjon
WO2001092247A3 (en) Preparation of 4-hydroxy-3[2h]-furanones
Nezbedová et al. Dihydroxyverbacine is the terminal precursor in the biosynthesis of aphelandrine and orantine
EP0823482A3 (en) A process for producing l-aspartic acid and converting maleic acid to fumaric acid
DE69618025D1 (de) Glucosesirup mit speziellen eigenschaften und verfahren zu seiner herstellung
EP0258666A3 (en) Microbial enzymatic transformations of chrysanthemol, lavandulol and analogous alcohols to acids
WO2004068139A3 (en) Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes
ATE361982T1 (de) Enon reduktase gen und mikrobielle herstellung von levodion

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase